Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support

[Display omitted]

Saved in:
Bibliographic Details
Published inJACC CardioOncology Vol. 4; no. 5; pp. 722 - 726
Main Authors Ramayya, Tarun, Mitchell, Joshua D., Hartupee, Justin C., Lavine, Kory, Ridley, Clare H., Kotkar, Kunal D., Jimenez, Jesus, Lin, Chieh-Yu, Alvarez-Cardona, Jose A., Krone, Ronald K., Campbell, Courtney M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2022
Elsevier
Subjects
abatacept
cardiac arrest
cardiogenic shock
cervical cancer
Clinical Case Challenges
extracorporeal membrane oxygenation
fulminant
heart failure
immune
immune checkpoint inhibitor
immunosuppressive
inflammation
inflammatory
myocarditis
troponin
T cell
immune checkpoint inhibitor
TTE
inflammatory
LVEF
cardiogenic shock
cardiac arrest
NT-proBNP
inflammation
fulminant
immunosuppressive
extracorporeal membrane oxygenation
heart failure
immune
abatacept
myocarditis
CMR
IVIG
hsTnI
LGE
cervical cancer
IV
ICI
IRAE
troponin
T cell
VA-ECMO
LVEF, left ventricular ejection fraction
hsTnI, high-sensitivity troponin I
LGE, late gadolinium enhancement
ICI, immune checkpoint inhibitor
CMR, cardiac magnetic resonance
NT-proBNP, N-terminal pro–B-type natriuretic peptide
TTE, transthoracic echocardiogram
IVIG, intravenous immunoglobulin
IV, intravenous
IRAE, immune-related adverse event
VA-ECMO, venoarterial extracorporeal membrane oxygenation
Online AccessGet full text

Cover

More Information
Summary:[Display omitted]
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2666-0873
2666-0873
DOI:10.1016/j.jaccao.2022.08.013